CV-05 (Cellivery)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCV-05 (Cellivery)
Drug Alias NameCV-05
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellivery Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellivery Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A